Naproxen Tablet
FDA Label NDC 51655-621

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Northwind Health Company, Llc for the product Naproxen (NDC 51655-621). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding how supplied, med guide for naproxen tablets usp 250 mg 375 mg 500 mg, 618r naproxen 500 mg 20 count, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

How Supplied

NAPROXEN TABLETS

500 MG: WHITE TO OFF-WHITE, CAPSULE-SHAPED TABLETS WITH “140” DEBOSSED ON ONE SIDE AND SCORED ON

OTHER SIDE. PACKAGED IN LIGHT-RESISTANT BOTTLES OF 100 AND 500.

20'S (BOTTLE): NDC 51655-621-20

60’S (BOTTLE): NDC 51655-621-25

180’S (BOTTLE): NDC 51655-621-83

STORE AT 20°-25°C (68°-77°F) EXCURSIONS PERMITTED TO 15°-30°C (59°-86°F) IN WELL-CLOSED CONTAINERS

[SEE USP CONTROLLED ROOM TEMPERATURE]. DISPENSE IN LIGHT-RESISTANT CONTAINERS.

RX ONLY

* Please review the disclaimer below.